Presentation Information

[28-09-am07S]Impact of co-administration of gastric acid suppressants on the effectiveness of CDK4/6 inhibitors in patients with endocrine-sensitive breast cancer

○Kaori Takahashi1, Ryuji Uozumi2, Toru Mukohara3, Shinya Takada4, Tetsu Hayashida5, Midori Iwabe6, Hirotoshi Iihara7, Kanako Kusuhara8, Kanae Tahatsu4, Aiko Nagayama5, Masami Tsuchiya1, Mika Kitahora7, Kengo Umehara4, Tomoko Seki5, Shinkichi Kosaka9, Yoshimi Niwa10, Kenichi Watanabe11, Koji Ohnuki12, Manabu Futamura10, Hitoshi Kawazoe5, Tomonori Nakamura1 (1. Keio Univ. Fac. Pharm., 2. Dept. Ind. Eng. and Econ.,Science Tokyo, 3. Dept. Med. Oncol., NCCE, 4. Dept. Pharm., National Hosp. Org. Hokkaido Cancer Center, 5. Keio Univ. Sch. Med., 6. Dept. Pharm., Miyagi Cancer Center, 7. Dept. Pharm., Gifu Univ. Hosp., 8. Dept. Pharm., NCCE, 9. Dept. Surg., National Hosp. Org. Mito Medical Center, 10. Dept. Breast Surg., Gifu Univ. Hosp., 11. Dept. Breast Surg., National Hosp. Org. Hokkaido Cancer Center, 12. Dept. Breast Surg., Miyagi Cancer Center)